Cannabis Science & Health
Colorado Regulators Recall Lead-laced Pre-rolls
State regulators in Colorado have issued a health and safety notice after “potentially unsafe levels” of lead were found in a batch of pre-roll cannabis joints.
Cannabis Labs in Washington Will Soon Be Required to Test For Pesticides
Cannabis testing labs in Washington will soon be required to test for pesticides.
Testing Psilocybin With Delic Labs' Eric Janusson
In a new Analytical Cannabis webinar held on March 8, Eric Janusson, lead chemist at the Vancouver-based Delic Labs, will present new methods being developed by Delic to produce accurate results for psilocybin quantitation. Here's what he had to say ahead of that webinar.
There Are No Major Differences Between an LSD and a Psilocybin Trip, Study Finds
After giving the drugs to participants and reviewing their experiences, the researchers concluded that both doses of LSD and the higher dose of psilocybin produced comparable psychedelic effects.
Waste Stream Management for Cannabis Operations
Cannabis companies produce their fair share of waste, and operators must dispose of it accordingly. But what does that involve? Analytical Cannabis spoke with Dr Susan Audino to find out.
THC Reduces Eye Pressure, Study Finds
The researchers say that more work is needed to determine the direct efficacy of THC in reducing intraocular pressure.
Cannabis Use Damages the Lungs in a Different Way to Tobacco, Study Finds
In the study, both tobacco and cannabis smokers had higher static lung scores, indicative of overinflated lungs, but the cannabis smokers had, on average, higher lung volumes and lower rates of gas transfer.
Microdosing LSD Doesn’t Work, Study Finds
Given the rising popularity of microdosing, the researchers say that more scientific study into the practice is urgently needed.
Psilocybin Therapy Still Benefits People With Depression One Year After Treatment, Study Finds
Almost all participants reported feeling significantly less depressed when they met up with the researchers a week after treatment, and most continued to report lower depression scores 3 months, 6 months, and 12 months after their psilocybin trip.
